SMTL ID : 4r1v.1

Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.20 Å

Oligo State

monomer

Ligands

1 x 3E8: 3-[1-(3-{5-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-2-yl}benzyl)-6-oxo-1,6-dihydropyridazin-3-yl]benzonitrile(Non-covalent)

3E8.1: 17 residues within 4Å: Chain A: I.30, A.54, L.86, L.103, P.104, Y.105, M.106, K.107, G.109, D.110, R.154, N.155, M.157, A.167, D.168, A.172, Y.176 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:A.54, A:L.86, A:L.103, A:M.106, A:D.110, A:A.167, A:D.168, A:Y.176, A:Y.176 Hydrogen bonds: A:M.106, A:D.168 Water bridges: A:N.113, A:D.177 pi-Stacking: A:Y.176

3 x GBL: GAMMA-BUTYROLACTONE(Non-covalent)

GBL.2: 9 residues within 4Å: Chain A: M.77, L.86, S.87, L.88, L.103, F.169, G.170, L.171, A.172 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:M.77, A:F.169, A:F.169 Hydrogen bonds: A:L.171 GBL.3: 5 residues within 4Å: Chain A: H.108, F.114, N.117, H.120, F.162 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:H.120 GBL.4: 7 residues within 4Å: Chain A: F.35, D.150, R.173, D.174, M.175, Y.181, K.190 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:K.190 Salt bridges: A:R.173

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Dorsch, D. et al., Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors. Bioorg.Med.Chem.Lett. (2015)

Release Date

2015-03-18

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor